Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380200478> ?p ?o ?g. }
- W4380200478 abstract "Abstract Objectives Eicosapentaenoic acid in its ethyl ester form is the single active component of icosapent ethyl (IPE). This study was a phase III, multi-center trial assessing the safety and efficiency of IPE for treating very high triglyceride (TG) in a Chinese cohort. Methods Patients having TG levels (5.6–22.6 mmol/L) were enrolled and randomly assigned to receive a treatment of oral intake of 4 g or 2 g/day of IPE, or placebo. Before and after 12 weeks of treatment, TG levels were assessed and the median was calculated to determine the change between the baseline and week 12. In addition to examining TG levels, the impact of such treatments on other lipid changes was also investigated. The official Drug Clinical Trial Information Management Platform has registered this study (CTR20170362). Results Random assignments were performed on 373 patients (mean age 48.9 years; 75.1% male). IPE (4 g/day) lowered TG levels by an average of 28.4% from baseline and by an average of 19.9% after correction for placebo (95% CI: 29.8%-10.0%, P < 0.001). In addition, plasma concentration of non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol, and VLDL-TG remarkedly reduced after IPE (4 g/day) treatment by a median of 14.6%, 27.9%, and 25.2%, respectively compared with participants in placebo group. Compared to the placebo, neither 4 nor 2 g of IPE daily elevated LDL-C levels with statistical significance. IPE was well tolerated by all the treatment groups. Conclusions IPE at 4 g/day dramatically lowered other atherogenic lipids without a noticeable increase in LDL-C, thereby decreasing TG levels in an exceptionally high-TG Chinese population." @default.
- W4380200478 created "2023-06-11" @default.
- W4380200478 creator A5006651636 @default.
- W4380200478 creator A5009737852 @default.
- W4380200478 creator A5011258773 @default.
- W4380200478 creator A5015813083 @default.
- W4380200478 creator A5018670108 @default.
- W4380200478 creator A5025999105 @default.
- W4380200478 creator A5028036693 @default.
- W4380200478 creator A5047434963 @default.
- W4380200478 creator A5056941518 @default.
- W4380200478 creator A5058678906 @default.
- W4380200478 creator A5063909163 @default.
- W4380200478 creator A5065058975 @default.
- W4380200478 creator A5073480094 @default.
- W4380200478 creator A5078164215 @default.
- W4380200478 creator A5083557168 @default.
- W4380200478 creator A5084136821 @default.
- W4380200478 creator A5087139691 @default.
- W4380200478 creator A5087981019 @default.
- W4380200478 creator A5091070290 @default.
- W4380200478 creator A5091534274 @default.
- W4380200478 date "2023-06-10" @default.
- W4380200478 modified "2023-09-27" @default.
- W4380200478 title "Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China" @default.
- W4380200478 cites W1520609538 @default.
- W4380200478 cites W1856460279 @default.
- W4380200478 cites W2039387229 @default.
- W4380200478 cites W2048070048 @default.
- W4380200478 cites W2079979713 @default.
- W4380200478 cites W2093598997 @default.
- W4380200478 cites W2099767767 @default.
- W4380200478 cites W2129659437 @default.
- W4380200478 cites W2145009492 @default.
- W4380200478 cites W2164324917 @default.
- W4380200478 cites W2165605025 @default.
- W4380200478 cites W2286999219 @default.
- W4380200478 cites W2340016801 @default.
- W4380200478 cites W2465758073 @default.
- W4380200478 cites W2596179513 @default.
- W4380200478 cites W2609543937 @default.
- W4380200478 cites W2746380101 @default.
- W4380200478 cites W2771532173 @default.
- W4380200478 cites W2787975960 @default.
- W4380200478 cites W2791364701 @default.
- W4380200478 cites W2794140214 @default.
- W4380200478 cites W2796185602 @default.
- W4380200478 cites W2807591881 @default.
- W4380200478 cites W2883340610 @default.
- W4380200478 cites W2899669642 @default.
- W4380200478 cites W2899720772 @default.
- W4380200478 cites W2899997727 @default.
- W4380200478 cites W2900151286 @default.
- W4380200478 cites W2920910705 @default.
- W4380200478 cites W2953804067 @default.
- W4380200478 cites W2969391566 @default.
- W4380200478 cites W2969523838 @default.
- W4380200478 cites W2973983647 @default.
- W4380200478 cites W2987000681 @default.
- W4380200478 cites W2990258037 @default.
- W4380200478 cites W3005344633 @default.
- W4380200478 cites W3011963422 @default.
- W4380200478 cites W3091533352 @default.
- W4380200478 cites W3103257019 @default.
- W4380200478 cites W3115132313 @default.
- W4380200478 cites W3183857127 @default.
- W4380200478 cites W4211134725 @default.
- W4380200478 cites W4213222556 @default.
- W4380200478 cites W4244896304 @default.
- W4380200478 cites W4376596387 @default.
- W4380200478 doi "https://doi.org/10.1186/s12944-023-01838-8" @default.
- W4380200478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37301827" @default.
- W4380200478 hasPublicationYear "2023" @default.
- W4380200478 type Work @default.
- W4380200478 citedByCount "0" @default.
- W4380200478 crossrefType "journal-article" @default.
- W4380200478 hasAuthorship W4380200478A5006651636 @default.
- W4380200478 hasAuthorship W4380200478A5009737852 @default.
- W4380200478 hasAuthorship W4380200478A5011258773 @default.
- W4380200478 hasAuthorship W4380200478A5015813083 @default.
- W4380200478 hasAuthorship W4380200478A5018670108 @default.
- W4380200478 hasAuthorship W4380200478A5025999105 @default.
- W4380200478 hasAuthorship W4380200478A5028036693 @default.
- W4380200478 hasAuthorship W4380200478A5047434963 @default.
- W4380200478 hasAuthorship W4380200478A5056941518 @default.
- W4380200478 hasAuthorship W4380200478A5058678906 @default.
- W4380200478 hasAuthorship W4380200478A5063909163 @default.
- W4380200478 hasAuthorship W4380200478A5065058975 @default.
- W4380200478 hasAuthorship W4380200478A5073480094 @default.
- W4380200478 hasAuthorship W4380200478A5078164215 @default.
- W4380200478 hasAuthorship W4380200478A5083557168 @default.
- W4380200478 hasAuthorship W4380200478A5084136821 @default.
- W4380200478 hasAuthorship W4380200478A5087139691 @default.
- W4380200478 hasAuthorship W4380200478A5087981019 @default.
- W4380200478 hasAuthorship W4380200478A5091070290 @default.
- W4380200478 hasAuthorship W4380200478A5091534274 @default.
- W4380200478 hasBestOaLocation W43802004781 @default.
- W4380200478 hasConcept C126322002 @default.
- W4380200478 hasConcept C142724271 @default.
- W4380200478 hasConcept C148257392 @default.